Nu Skin Enterprises, Inc. (NUS) SEC filings

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value

$4.01+0.12 (+3.08%)

Close on Nov 12, 2026Market cap $195.19MP/E –Yield –

SEC filings

40 of Nu Skin Enterprises's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 6, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Aug 17, 2026	Aug 21, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	May 28, 2026	May 29, 2026	SEC EDGAR
Current report	8-K	May 6, 2026	May 8, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 8, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 28, 2026	Apr 3, 2026	SEC EDGAR
Current report	8-K	Mar 27, 2026	Mar 27, 2026	SEC EDGAR
Current report	8-K	Mar 17, 2026	Mar 20, 2026	SEC EDGAR
Current report	8-K	Mar 5, 2026	Mar 9, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 13, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 7, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 8, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	May 29, 2025	May 30, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 9, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Proxy statement	DEF 14A	May 29, 2025	Apr 4, 2025	SEC EDGAR
Current report	8-K	Mar 5, 2025	Mar 6, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 14, 2025	SEC EDGAR
Current report	8-K	Feb 13, 2025	Feb 13, 2025	SEC EDGAR
Current report	8-K	Jan 13, 2025	Jan 13, 2025	SEC EDGAR
Current report	8-K	Jan 2, 2025	Jan 3, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 8, 2024	SEC EDGAR
Current report	8-K	Nov 7, 2024	Nov 7, 2024	SEC EDGAR
Current report	8-K	Oct 31, 2024	Nov 1, 2024	SEC EDGAR
Current report	8-K	Sep 10, 2024	Sep 12, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 9, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Jun 5, 2024	Jun 6, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 9, 2024	SEC EDGAR
Current report	8-K	May 8, 2024	May 8, 2024	SEC EDGAR
Proxy statement	DEF 14A	Jun 5, 2024	Apr 12, 2024	SEC EDGAR
Current report	8-K	Mar 15, 2024	Mar 18, 2024	SEC EDGAR
Annual report	10-K	Dec 31, 2023	Feb 15, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Nu Skin Enterprises's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NUS.

Compare: NUS vs HLF · NUS vs USNA · NUS vs COSM · NUS vs ASH · NUS vs NATR

Revenue growth-15.3% · median 1.2%

Gross margin67.8% · median 73.1%

Operating margin-2.0% · median 5.3%

Net margin-17.7% · median 0.4%

Company	Revenue	Growth
HLF	$5.28B	+6.4%
ASH	$1.84B	-1.4%
NUS	$1.32B	-15.3%
USNA	$905.58M	-0.8%
NATR	$480.29M	+1.2%
COSM	$73.73M	+33.8%

Company

Next earnings (est.): Feb 11, 2027, during market hours
Exchange: NYSE
Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year ends: December 31
Employees: 2,800
Held by institutions: 74.4%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1021561

Advertisement
300 × 250

See a number that looks wrong?